Connect with us

Life Sciences

StartUp Health Insights: Healthcare Workforce Marketplace Raises $200M | Week of Feb 7, 2023

In addition to $200M for ShiftMed, this week’s global digital health funding went to startups focused on data transparency, behavioral and mental health, cardiac support systems, chronic cough, breast cancer, digital storefronts for doctors, and more.I…

Published

on

This article was originally published by Stories by StartUp Health on Medium

In addition to $200M for ShiftMed, this week’s global digital health funding went to startups focused on data transparency, behavioral and mental health, cardiac support systems, chronic cough, breast cancer, digital storefronts for doctors, and more.

Investors, contact us to learn how you can back Health Moonshots.

This week’s reported health innovation funding included:

ShiftMed, a McLean, VA-based healthcare workforce management marketplace, raised $200M led by Panoramic Ventures, with participation from Blue Heron Capital and Audacious Capital. <source>

Clearsense, a Jacksonville, FL-based company that partners with healthcare organizations to increase data value, governance, and transparency, raised $50M led by HealthQuest Capital, with participation from Health Catalyst Capital and UPMC Enterprises. <source>

NOCD, a Chicago, IL-based behavioral health tech company, raised $34M co-led by Cigna Ventures and 7wireVentures, with participation from Kaiser Permanente Ventures, F-Prime Capital, Eight Roads Capital, Health Enterprise Partners, and Longitude Capital. <source>

Alto Neuroscience, a Los Altos, CA-based company that uses AI to identify biomarkers to develop targeted psychiatric medicine options, raised $35M led by Lightswitch Capital and partners of Alkeon Capital, with participation from Sobrato Capital, Novartis Pharma AG, Valor Equity Partners, Korify Capital, Vine Ventures, Gaingels, Apeiron Group, WhatIf Ventures, Windham Venture Partners, and others.. <source>

Evonetix, a Cambridge, UK-based synthetic biology company bringing semiconductor technology to DNA synthesis, raised $24M (£20M) led by Foresite Capital, with participation from Molten Ventures, Morningside, DCVC, Cambridge Consultants, Civilization Ventures, and Providence. <source>

Syntach, a Lund, Sweden-based developer of innovative cardiac support systems, raised €17.5M ($16.3M) from the European Innovation Council. <source>

Aluna, a San Francisco, CA-based lung health management platform, raised $15.3M led by Matrix Partners, with participation from Rho Ignition and Dr. Warner Carr. <source>

AnswersNow, a Richmond, VA-based virtual ABA autism therapy platform, raised $11M led by Left Lane Capital, with participation from American Family Institute for Social Impact, Blue Heron Capital, Difference Partners, and Lani Fritts. <source>

Doctify, a London, UK-based provider of a platform for patient reviews of health and social care, raised $10M led by Beringea, with participation from Keen Venture Partners, Amadeus Capital Partners, and Guinness Ventures. <source>

Simple HealthKit, a Fremont, CA-based end-to-end healthcare platform that builds and delivers diagnostics, treatment, and follow-up care for all, raised $8M led by Initialized Capital, with participation from Kleiner Perkins, Kapor Capital, and Quest Venture Partners. <source>

Levels, a New York, NY-based startup that provides real-time feedback on how food affects health, raised $7M from TriplePoint Capital. <source>

C-mo Medical Solutions, an Almada, Portugal-based digital health startup focused on assessing chronic cough, raised €4.8M ($5.2M) led by Boehringer Ingelheim Venture Fund, with participation from Portugal Ventures, High-Tech Gründerfonds, and Novalis Biotech. <source>

Re:course AI, a Manchester, UK-based medical training simulator, raised $4.3M led by Par Equity, with participation from Northern Gritstone, GMC Life Sciences Fund by Praetura, and angel investors. <source>

Frontrow Health, an Austin, TX-based platform enabling medical providers to build personalized digital storefronts, raised $3M from Next Coast Ventures, NextGen Venture Partners, and angel investors. <source>

Mica AI Medical, a Tel Aviv, Israel-based provider of technology for early detection and diagnosis of breast cancer, raised $3M led by Haim Chizic, Tzachi Arabov, Daniel Koss, BNP VC, Israeli Innovation Authority, and the Ministry of Economy. <source>

Data is from StartUp Health Insights, the most comprehensive funding database for health innovation. Get all our free quarterly reports and sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.

Passionate about breaking down health barriers? If you’re an entrepreneur or investor, contact us to learn how you can join our Health Equity Moonshot.

Investors: Contact us to learn how you can invest in Health Transformers and Health Moonshots.

Digital health entrepreneur? Don’t make the journey alone. Learn more about the StartUp Health Community and how StartUp Health invests.

Follow us on social media for daily updates on Health Transformers: Twitter, LinkedIn, Facebook, and Instagram.


StartUp Health Insights: Healthcare Workforce Marketplace Raises $200M | Week of Feb 7, 2023 was originally published in StartUp Health on Medium, where people are continuing the conversation by highlighting and responding to this story.

diagnostics
biomarkers
medical
biotech
pharma
life sciences
healthcare
digital health
ai
medicine
vc
fund

Life Sciences

Wittiest stocks:: Avalo Therapeutics Inc (NASDAQ:AVTX 0.00%), Nokia Corp ADR (NYSE:NOK 0.90%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Life Sciences

Spellbinding stocks: LumiraDx Limited (NASDAQ:LMDX 4.62%), Transocean Ltd (NYSE:RIG -2.67%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Life Sciences

Asian Fund for Cancer Research announces Degron Therapeutics as the 2023 BRACE Award Venture Competition Winner

The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition….

Continue Reading

Trending